...
首页> 外文期刊>Helvetica chimica acta >OLIGOSACCHARIDES RELATED TO TUMOR-ASSOCIATE ANTIGENS .3. SYNTHESIS OF THE PROPYL GLYCOSIDES OF THE TRISACCHARIDE BETA-D-GALP-(1-]3)-BETA-D-GALPNAC-(1-]3)-ALPHA-D-GALP AND OF THE TETRASACCHARIDE ALPHA-L-FUCP-(1-]2)-BETA-D-GALP-(1-]3)-BETA-D-GALPNAC-(1
【24h】

OLIGOSACCHARIDES RELATED TO TUMOR-ASSOCIATE ANTIGENS .3. SYNTHESIS OF THE PROPYL GLYCOSIDES OF THE TRISACCHARIDE BETA-D-GALP-(1-]3)-BETA-D-GALPNAC-(1-]3)-ALPHA-D-GALP AND OF THE TETRASACCHARIDE ALPHA-L-FUCP-(1-]2)-BETA-D-GALP-(1-]3)-BETA-D-GALPNAC-(1

机译:与肿瘤相关抗原有关的寡糖3。三糖β-D-GALP-(1-] 3)-BET-D-GALPNAC-(1-] 3)-α-D-GALP和四糖α-L-FUCP-( 1-] 2)-BETA-D-GALPAC-(1-] 3)-BETA-D-GALPNAC-(1

获取原文
获取原文并翻译 | 示例
           

摘要

The synthesis of the trisaccharide P-D-Galp-(1 --> 3)-beta-D-GalpNAc-(l --> 3)-alpha-D-Galp-l-OPr (2) and of the tetrasaccharide alpha-L-Fucp-(1 --> 2)-beta-D-Galp-(1 --> 3)-beta-D-Galp (3), starting from the disaccharidic dihydrooxazole donor 5, is described. Glycosylation of 5 with 6 in the presence of Me(3)SiOTf gave the trisaccharide 7 which was deprotected with standard methods to give, via 8, compound 2 (Scheme I). Alternatively, protection of 8 as the 4',6'-O-benzylidene derivative 9 followed by glycosylation with 10 and by standard deprotection afforded the tetrasaccharide 3 (Scheme 2). Biological testing showed that trisaccharide 2 is unable to inhibit the binding of the monoclonal antibody MBr1 to the target tumor cells MCF7, while tetrasaccharide 3 inhibits the binding in ca. 7-fold extent with respect to the previously tested trisaccharide alpha-L-Fucp-(1 --> 2)-beta-DGalp-(1 --> 3)-beta-D-GalpNAc-1-OPr. These results indicate that the galactose corresponding to the unit D of compound 1 plays an important role in; defining the MBrl-recognized epitope and confirm the essential role of fucose for MAb recognition. [References: 10]
机译:三糖PD-Galp-(1-> 3)-β-D-GalpNAc-(1-> 3)-α-D-Galp-1-OPr(2)和四糖α-L的合成描述了从二糖二氢恶唑供体5开始的-Fucp-(1→2)-β-D-Galp-(1→3)-β-D-Galp(3)。在Me(3)SiOTf存在下5与6的糖基化得到三糖7,该三糖用标准方法脱保护,通过8生成化合物2(方案I)。或者,将8保护为4',6'-O-亚苄基衍生物9,然后用10进行糖基化并通过标准脱保护得到四糖3(方案2)。生物学测试表明,三糖2不能抑制单克隆抗体MBr1与靶肿瘤细胞MCF7的结合,而四糖3则可以抑制约3的结合。相对于先前测试的三糖α-L-Fucp-(1-> 2)-β-DGalp-(1-> 3)-β-D-GalpNAc-1-OPr,是7倍范围。这些结果表明与化合物1的单元D相对应的半乳糖起着重要的作用。定义了MBr1识别的表​​位,并确定了岩藻糖对于MAb识别的重要作用。 [参考:10]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号